Genetic contribution to colorectal cancer in Newfoundland and Labrador based on family history and tumour molecular analyses for an incident cohort

Background and Purpose: Colorectal cancer (CRC) is an insidious cancer associated with significant morbidity and mortality. In Canada, it is the second leading cause of cancer death. Newfoundland and Labrador has the highest rate of CRC of all ten Canadian provinces and is ideal for examining founde...

Full description

Bibliographic Details
Main Author: Crane, Amanda
Format: Thesis
Language:English
Published: Memorial University of Newfoundland 2012
Subjects:
Online Access:https://research.library.mun.ca/6101/
https://research.library.mun.ca/6101/1/Crane_Amanda.pdf
https://research.library.mun.ca/6101/3/Crane_Amanda.pdf
Description
Summary:Background and Purpose: Colorectal cancer (CRC) is an insidious cancer associated with significant morbidity and mortality. In Canada, it is the second leading cause of cancer death. Newfoundland and Labrador has the highest rate of CRC of all ten Canadian provinces and is ideal for examining founder effects and studying incidence of hereditary disease in what is essentially a closed community. Family history is the strongest risk factor for this disease. Inherited deleterious variants in the mismatch repair (MMR) genes play a critical role in the development of some cases, but families exist who have a family history consistent with autosomal dominant inheritance and no known predisposing genes (Familial colorectal cancer type X, FCCTX). The aim of this study is to determine the genetic basis of CRC in Newfoundland and Labrador, defined by family history, molecular pathology of the CRC and molecular genetics, in an incident cohort of CRC cases occurring in the population during one year. -- Methods: A study population of 262 consecutively diagnosed CRC cases from the Newfoundland population were identified and following application of the recruitment protocol 148 participants, 144 families, completed the study. Eligible probands were contacted for consent and with this permission tumour blocks were obtained. Detailed family histories were obtained and risk classified. Tests of microsatellite stability and immunohistochemistry for mismatch repair proteins in tumour blocks were performed. Cancer phenotypes in family members of patients with CRC were compared in various high risk groups. -- Results: 12.5% of families (n=18) were classified as high risk according to Amsterdam criteria (AC) and Age and Cancer modified Amsterdam criteria (ACMAC). An additional 33.3% fulfilled the revised Bethesda guidelines for intermediate risk classification and 53.5% were low risk. Fifteen (10.9%) families demonstrated microsatellite instability with thirteen (86.7%) of these having a corresponding deficiency in mismatch repair ...